Skip to the page

Data / Drug companies / Icosapent ethyl

Icosapent ethyl: 21 companies and 39 products in the FDA NDC directory

Icosapent ethyl is listed in the FDA National Drug Code Directory by 21 companies, with 39 products in commercial distribution. 34 of the products (87.2%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are capsule; capsule, liquid filled, and the newest product started marketing on June 24, 2026.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Companies listing it
21
Products
39
Generic (ANDA) products
34 (87.2%)
Application numbers
12
Routes
Oral
Brand names
Vascepa, Icosapent
openFDA record search
api.fda.gov

Companies that list icosapent ethyl

Ranked by number of products. Finished drugs in commercial distribution.

CompanyProductsMain dosage formsMain marketing categoryNewest product started
Amarin Pharma Inc.4capsuleNew drug applications (NDA)December 5, 2025
Bryant Ranch Prepack4capsule; capsule, liquid filledGeneric drugs (ANDA)February 16, 2024
Bryant Ranch Prepack3capsuleGeneric drugs (ANDA)June 21, 2021
Epic Pharma, LLC3capsule, liquid filledGeneric drugs (ANDA)December 22, 2023
Amneal Pharmaceuticals NY LLC2capsuleGeneric drugs (ANDA)November 1, 2023
Camber Pharmaceuticals, Inc.2capsuleGeneric drugs (ANDA)February 16, 2024
Dr. Reddy's Laboratories Inc.2capsuleGeneric drugs (ANDA)April 17, 2023
Hikma Pharmaceuticals USA Inc.2capsuleGeneric drugs (ANDA)November 4, 2020
Softgel Healthcare Pvt Ltd2capsuleGeneric drugs (ANDA)March 1, 2025
Teva Pharmaceuticals, Inc.2capsule, liquid filledGeneric drugs (ANDA)December 15, 2022
XLCare Pharmaceuticals, Inc.2capsuleGeneric drugs (ANDA)February 16, 2024
Zydus Pharmaceuticals USA Inc.2capsuleGeneric drugs (ANDA)August 4, 2023
American Health Packaging1capsuleGeneric drugs (ANDA)February 21, 2024
Apotex Corp.1capsuleGeneric drugs (ANDA)December 16, 2021
Aurobindo Pharma Limited1capsuleGeneric drugs (ANDA)June 24, 2026
Bryant Ranch Prepack1capsuleGeneric drugs (ANDA)November 4, 2020
Golden State Medical Supply, Inc.1capsuleGeneric drugs (ANDA)June 30, 2021
NorthStar Rx LLC1capsuleGeneric drugs (ANDA)July 1, 2025
NorthStar RxLLC1capsuleGeneric drugs (ANDA)November 4, 2020
Qilu Pharmaceutical Co., Ltd.1capsuleGeneric drugs (ANDA)January 1, 2025
Vitruvias Therapeutics1capsuleGeneric drugs (ANDA)October 20, 2025

Dosage forms

Dosage formProductsShare
Capsule3384.6%
Capsule, liquid filled615.4%

Marketing categories

Marketing categoryProductsShare
Generic drugs (ANDA)3487.2%
New drug applications (NDA)512.8%

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.